---
title: "COX10"
date: 2023-05-12 00:00:00
layout: post
categories: Gene
summary: "# Genetic Information of Gene COX10"
tags: ['COX10', 'MitochondrialEnergyProduction', 'MissenseMutation', 'COXPD23', 'LacticAcidemia', 'HypertrophicCardiomyopathy', 'Encephalopathy', 'SupportiveCare']
---

# Genetic Information of Gene COX10

## Gene Information
- **Gene Name**: COX10
- **Function**: Encodes a protein that is involved in the function of cytochrome c oxidase, an enzyme complex responsible for mitochondrial energy production through oxidative phosphorylation.
- **External IDs**: 
    - HGNC: 2257
    - NCBI Entrez Gene: 1353
    - Ensembl: ENSG00000167711
    - OMIM: 602125
    - UniProtKB/Swiss-Prot: Q12887
- **Aliases**: COX10C, COX10H, COX10L
- **Genomic Location**: Chromosome 17q25.1

## Mutation Information
- **AA Mutation List**: 
    - p.Asn131Ser
    - p.Leu216Trp
    - p.Asp212Asn
    - p.Pro187Leu
- **Mutation Type**: Missense Mutation
- **dbSNP ID**:
    - rs104894579
    - rs878853975
    - rs138527447
    - rs879255196
- **Somatic SNVs/InDels**:
    - Not applicable

## Pathology
- **Related Disease**:
    - COXPD23: A rare autosomal recessive disorder that is caused by mutations in the COX10 gene. It is characterized by lactic acidemia, hypertrophic cardiomyopathy, and encephalopathy.
- **Treatment and Prognosis**:
    - Treatment options for COXPD23 are supportive and include proper monitoring of cardiac function and management of lactic acidosis.
    - The prognosis for COXPD23 is variable and depends on the severity of the disease and the availability of supportive care.
- **Drug Response**:
    - There is no known drug response for COXPD23.

## Related Papers
- **Subject**: COX10 Pathogenic Variants Cause a Phenotypic Spectrum
- **Author**: Víctor Andrés-Lacueva et al.
- **DOI**: [Click](https://doi.org/10.3389/fgene.2020.00014)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**